
IFF Stock Forecast & Price Target
IFF Analyst Ratings
Bulls say
International Flavors & Fragrances (IFF) has demonstrated strong financial performance, with net sales of $2,771 million in 3Q24 representing a 3% year-over-year increase and surpassing consensus estimates. The company has seen consistent acceleration in volume growth, achieving high single-digit growth for the fifth consecutive quarter, driven by broad advancements across all business segments, including a notable improvement in Functional Ingredients. Furthermore, organic sales growth is anticipated to remain positive at 1-4% for FY25, supported by improved trends among global consumer staples companies that serve as a proxy for IFF's customer base.
Bears say
International Flavors & Fragrances faces significant downside risks due to macroeconomic weakness impacting customer demand and heightened competitive pressure, alongside rising input costs and unfavorable foreign exchange rates, which have adversely affected EBITDA more than initially anticipated. Following the planned divestiture of the Pharma segment expected to close in mid-2025, leverage is projected to reduce to approximately 3x by year-end 2025, though current leverage stands at 3.9x as of Q3 2024, indicating ongoing financial strain. Consequently, revenue and earnings per share estimates for 2025-2026 have been revised downward, reflecting the impact of the Pharma sale and recent negative currency fluctuations.
This aggregate rating is based on analysts' research of International Flavors & Fragrances and is not a guaranteed prediction by Public.com or investment advice.
IFF Analyst Forecast & Price Prediction
Start investing in IFF
Order type
Buy in
Order amount
Est. shares
0 shares